Revolution Medicines, Inc. (RVMD)

177.96 -11.30 (-5.97%) USD  |  NASDAQ  |  Oct 16, 16:00
177.47 -0.49 (-0.28%) After-Hours: 20:00
More

Revolution Medicines Cash from Investing (Quarterly) : -1.659B for June 30, 2026

Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -1.659B
March 31, 2026 172.62M
December 31, 2025 74.88M
September 30, 2025 24.85M
June 30, 2025 34.28M
March 31, 2025 -15.95M
December 31, 2024 -392.90M
September 30, 2024 -21.47M
June 30, 2024 107.94M
March 31, 2024 -247.97M
December 31, 2023 -380.40M
September 30, 2023 77.35M
June 30, 2023 -43.54M
March 31, 2023 3.996M
December 31, 2022 -7.104M
Date Value
September 30, 2022 -123.44M
June 30, 2022 62.40M
March 31, 2022 44.02M
December 31, 2021 8.533M
September 30, 2021 -30.18M
June 30, 2021 -122.78M
March 31, 2021 2.309M
December 31, 2020 62.95M
September 30, 2020 -100.97M
June 30, 2020 -136.50M
March 31, 2020 -59.72M
December 31, 2019
September 30, 2019
June 30, 2019 -55.95M
March 31, 2019 5.761M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Moderna, Inc. 329.00M
Arrowhead Pharmaceuticals, Inc. 43.68M
Intellia Therapeutics, Inc. -141.57M
Oncolytics Biotech, Inc. 0.00
Twist Bioscience Corp. -10.20M

Cash from Investing (Quarterly) Related Metrics

Cash from Operations (Quarterly) -387.32M
Cash from Financing (Quarterly) 2.420B
Free Cash Flow -1.232B
Free Cash Flow Per Share (Quarterly) -1.847
Free Cash Flow to Equity (Quarterly) -1.143B
Free Cash Flow to Firm (Quarterly) -365.82M
Free Cash Flow Yield -3.48%